NCT05784415 Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell Status COMPLETED Phase N/A
NCT05763563 Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy Status COMPLETED Phase NA
NCT05745285 Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care Status RECRUITING Phase NA
NCT05743465 A Study to Evaluate Available Treatment Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and Nilotinib in Adults With Chronic Myeloid Leukemia Status COMPLETED Phase N/A
NCT05692713 Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201) Status RECRUITING Phase N/A
NCT05691608 MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2 Status RECRUITING Phase NA
NCT05673057 Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome Status RECRUITING Phase PHASE1/PHASE2
NCT05655546 ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals Status TERMINATED Phase NA
NCT05646576 Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy Status RECRUITING Phase NA
NCT05645718 Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia Status RECRUITING Phase PHASE2
NCT05635266 Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives Status RECRUITING Phase N/A
NCT05544968 Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies Status RECRUITING Phase PHASE1
NCT05536349 Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT) Status RECRUITING Phase PHASE2
NCT05528887 Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies Status RECRUITING Phase PHASE1
NCT05480501 Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia Status UNKNOWN Phase EARLY_PHASE1
NCT05479994 Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05464836 Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL Status TERMINATED Phase PHASE2
NCT05425992 Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families Status RECRUITING Phase N/A